Supplement encyclopedia

Avena sativa

Common oat (Avena sativa) is a cereal plant used to make groats, oat flakes, bran, and supplements. The grain contains beta-glucan, a soluble dietary fiber. Extracts from the green part of the plant differ in composition from the grain and from beta-glucan.

Double-check the conclusions and review the sources before choosing a supplement.

Main conclusion

Potential benefits

  • In adults with high cholesterol, oat foods containing beta-glucan lowered “bad” LDL cholesterol by an average of 0.27 mmol/L more than comparison foods over 3–8 weeks.
  • A separate trial of CP105F oat beta-glucan tablets found no convincing reduction in LDL compared with placebo over 12 weeks.
  • When oat beta-glucan was added to a meal, the total glucose rise afterward was an average of 23% smaller than after a meal with a comparable amount of digestible carbohydrates without added beta-glucan. Both the height and duration of the rise were taken into account.
  • After an oatmeal breakfast, healthy adults felt fuller for four hours and ate an average of 85 kcal less at lunch than after a dry breakfast cereal with the same calorie content.
  • The green oat extract cognitaven may help improve accuracy on tasks requiring tracking a moving target while counting aloud, as well as remembering block sequences. This improvement was observed by day 29 in healthy adults aged 35–65.
  • In healthy people over 60, another green oat extract, Neuravena, showed no advantage in attention and concentration tests over 12 weeks.

[1] [2] [3] [4] [5] [6] [7]

What was studied

  • To lower LDL, studies of oat foods used 1.5–6 g of beta-glucan daily. For post-meal outcomes, researchers studied beta-glucan or bran rich in it added to a single meal.
  • With celiac disease, choose oats labeled “gluten-free”: ordinary products may be contaminated with wheat, rye, or barley. With oat allergy, avoid oat foods and supplements.
  • EMA does not recommend oat herb preparations for children under 12 or during pregnancy and breastfeeding because of insufficient data. These conditions apply to herb preparations.

[1] [2] [3] [4] [5] [6]

Which forms were studied

  • Oat flakes, bran, and grain contain beta-glucan as part of their dietary fiber. Total fiber on the package and beta-glucan content are different measures.
  • The satiety study used 66.8 g of dry oat flakes containing 2.68 g of beta-glucan, prepared with water and skimmed lactose-free milk.
  • Cognitaven contains 70% green oat extract: 430 and 1290 mg of the product correspond to 300 and 900 mg of extract. Neuravena was studied separately at 1500 mg of extract daily.

[1] [2] [3] [4] [5]

How to get it from food

  • A 40 g portion of dry unenriched oat flakes contains about 152 kcal, and 20 g of dry oat bran about 49 kcal.
  • A 150 g portion of cooked oat bran porridge contains about 60 kcal; 30 g of ready-to-eat oat bran bread contains about 71 kcal.
  • Check the package for the beta-glucan amount: the weight of flakes or bran alone does not indicate it.

[1] [2]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
LDL (“bad”) cholesterol: oat productsLDL was 0.27 mmol/L lower on average than in the control group (95% confidence interval for the reduction, 0.20–0.35 mmol/L).
2/4 LowThe review included 13 trials covering different lipid outcomes. Twelve measured LDL, and one trial contributed two dose comparisons. Results varied considerably across products and studies (I² = 83.3%). The average reduction cannot be attributed to each individual supplement. This finding applies to adults with high cholesterol. It does not show how much LDL would fall in someone whose LDL is already in the normal range.
11 publicationEffects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗Adults with high cholesterol, with 12 trials and 13 dose comparisons for LDL
  1. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
LDL (“bad”) cholesterol: beta-glucan tabletsLDL did not decrease compared with placebo. Changes at 1.5, 3, and 6 g per day were +0.08, +0.11, and −0.04 mmol/L, respectively, compared with −0.10 mmol/L with placebo. The corresponding p-values were 0.23, 0.18, and 0.72.
3/4 ModerateEach beta-glucan group had 66 participants, and the placebo group had 65. None of the three comparisons showed a convincing reduction in LDL. This result comes from a 12-week trial of a single tablet formulation. Oat products were studied separately.
11 publicationSupplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗263 adults with LDL above 3.37 mmol/L, including people who were taking statins and people who were not
  1. Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗
Rise in blood glucose after a mealThe total rise in glucose over the post-meal period was 23% lower on average, with a ratio of 0.77 relative to the control (95% confidence interval 0.74–0.81). This was measured as the incremental area under the glucose curve, which captures both the size and duration of the rise. The peak is a separate measure.
3/4 ModerateThe comparisons covered different meals, doses, and types of beta-glucan, and results varied (I² = 59.9%). Most comparisons involved healthy people, but the overall estimate also includes the other groups listed. The review included 31 studies and 103 comparisons across several outcomes. This result used 98 comparisons. Multiple comparisons from the same study do not count as separate independent studies. The studies measured the response to a single meal. This result does not describe long-term changes in fasting blood sugar or HbA1c.
22 publications: a meta-analysis and an EFSA scientific opinionThe effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis ↗508 participants across 98 comparisons, including healthy adults and people with overweight, type 2 diabetes, or metabolic syndrome
  1. The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis ↗
  2. Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Beta-glucan in food: conditions reviewed by EFSA
PurposeAmountHow to interpret it
Reducing the peak rise in blood glucose after a mealAt least 3 g of oat beta-glucan per 30 g of digestible carbohydrates, with at least 30 g of those carbohydrates in the servingThis is a condition for foods in EFSA’s 2026 scientific opinion. It is neither a daily requirement nor a safe upper limit. Digestible carbohydrates exclude dietary fiber.

Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ↗

Forms

Oat products. Oat grain, rolled oats, and oat bran contain a mix of dietary fibers. Beta-glucan is only one component of that mix. Cholesterol studies used 1.5–6 g of beta-glucan per day. A separate study on fullness used 66.8 g of dry rolled oats containing a measured 2.68 g of beta-glucan. CP105F tablets. Researchers studied 1.5, 3, and 6 g of beta-glucan per day. Over 12 weeks, the tablets did not lower LDL compared with placebo. Green oat extracts. cognitaven contains 70% extract and 30% excipients. Therefore, 430, 860, and 1,290 mg of product correspond to 300, 600, and 900 mg of extract. Neuravena was studied separately at 1,500 mg of extract per day. These doses cannot be converted into servings of oatmeal.

Guidance for each goal

LDL (“bad”) cholesterol: oat products2/4 LowRead moreCollapse
Confidence
2/4 LowThe review included 13 trials covering different lipid outcomes. Twelve measured LDL, and one trial contributed two dose comparisons. Results varied considerably across products and studies (I² = 83.3%). The average reduction cannot be attributed to each individual supplement. This finding applies to adults with high cholesterol. It does not show how much LDL would fall in someone whose LDL is already in the normal range.

A small average reduction in LDL.

Study findings. LDL was 0.27 mmol/L lower on average than in the control group (95% confidence interval for the reduction, 0.20–0.35 mmol/L).

Studied regimen1.5–6 g of oat beta-glucan per dayOat milk, oat grain and porridge, rolled oats, bread, cookies, bars, soup, and beta-glucan concentrate
Duration and population3–8 weeksAdults with high cholesterol, with 12 trials and 13 dose comparisons for LDL

Comparator: Products without added oat beta-glucan, such as bread, cornflakes, rice, a dairy product, or dextrose

LDL (“bad”) cholesterol: beta-glucan tablets3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateEach beta-glucan group had 66 participants, and the placebo group had 65. None of the three comparisons showed a convincing reduction in LDL. This result comes from a 12-week trial of a single tablet formulation. Oat products were studied separately.

No benefit over placebo was detected.

Study findings. LDL did not decrease compared with placebo. Changes at 1.5, 3, and 6 g per day were +0.08, +0.11, and −0.04 mmol/L, respectively, compared with −0.10 mmol/L with placebo. The corresponding p-values were 0.23, 0.18, and 0.72.

Studied regimen1.5, 3, or 6 g of beta-glucan per day, taken as 1, 2, or 4 tablets three times a dayCP105F oat beta-glucan tablets containing 0.5 g of beta-glucan each
Duration and population12 weeks263 adults with LDL above 3.37 mmol/L, including people who were taking statins and people who were not

Comparator: Placebo tablets

Rise in blood glucose after a meal3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateThe comparisons covered different meals, doses, and types of beta-glucan, and results varied (I² = 59.9%). Most comparisons involved healthy people, but the overall estimate also includes the other groups listed. The review included 31 studies and 103 comparisons across several outcomes. This result used 98 comparisons. Multiple comparisons from the same study do not count as separate independent studies. The studies measured the response to a single meal. This result does not describe long-term changes in fasting blood sugar or HbA1c.

Reduced the total rise in glucose after a meal on average.

Study findings. The total rise in glucose over the post-meal period was 23% lower on average, with a ratio of 0.77 relative to the control (95% confidence interval 0.74–0.81). This was measured as the incremental area under the glucose curve, which captures both the size and duration of the rise. The peak is a separate measure.

Studied regimen0.21–11.7 g of beta-glucan per meal in the comparisons for this outcomeOat beta-glucan or beta-glucan-rich oat bran added to a food or drink
Duration and populationOne meal, with measurements over 60–240 minutes508 participants across 98 comparisons, including healthy adults and people with overweight, type 2 diabetes, or metabolic syndrome

Comparator: A food or drink without added beta-glucan and with a comparable amount of digestible carbohydrates

Fullness after an oatmeal breakfast2/4 LowRead moreCollapse
Confidence
2/4 LowEach participant tried both breakfasts, which helps account for individual differences. However, the oatmeal and breakfast cereal looked noticeably different. The study compared two specific breakfasts. They differed in beta-glucan, sugar, protein, and other properties. The study measured the response to one meal. It did not assess weight loss. Quaker/PepsiCo funded the study, and some authors worked for PepsiCo.

The oatmeal was more filling than the breakfast cereal it was compared with.

Study findings. Participants felt fuller over the four hours after eating the oatmeal. The cumulative fullness score over that period was 11,486 versus 9,443 point·min on a 100-point scale (p = 0.001).

Studied regimen66.8 g of dry oat flakes (2.68 g of beta-glucan), 360 g of water, and 307 g of fat-free, lactose-free milk, totaling 363 kcalQuaker Instant Oatmeal porridge with milk
Duration and populationOne breakfast with 4 hours of observation. The two test days were at least one week apart.48 healthy adults aged 19–63, each of whom tried both breakfasts

Comparator: 63.6 g of Honey Nut Cheerios with the same 307 g of milk, plus 360 g of water to drink, totaling 363 kcal

Food intake at the next lunch2/4 LowRead moreCollapse
Confidence
2/4 LowFood intake was measured by weighing portions before and after lunch. Each participant tried both breakfasts. The food intake and fullness findings came from the same experiment with 48 participants and count as results from a single study. The 85 kcal reduction applies to one lunch. The study did not measure weight change or subsequent food intake. Quaker/PepsiCo funded the study.

Participants ate slightly less at the next lunch.

Study findings. Four hours after eating the oatmeal, participants ate an average of 85 kcal less at lunch than after eating the breakfast cereal (p = 0.012). Drinks were excluded from this estimate.

Studied regimen66.8 g of dry oat flakes (2.68 g of beta-glucan), 360 g of water, and 307 g of fat-free, lactose-free milk, totaling 363 kcalQuaker Instant Oatmeal porridge with milk
Duration and populationLunch 4 hours after a single breakfast, with at least one week between test days48 healthy adults aged 19–63 in the same experiment comparing two breakfasts

Comparator: A breakfast of 63.6 g of Honey Nut Cheerios with the same milk and the same energy content of 363 kcal

Tracking a moving target: cognitaven2/4 LowRead moreCollapse
Confidence
2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company.

Improvement on a specific task that involved doing arithmetic at the same time.

Study findings. On day 29, participants tracked a moving target more accurately with a cursor while subtracting numbers aloud. The standardized difference versus placebo was d = 0.54 at 430 mg (p = 0.032) and d = 0.94 at 1,290 mg (p < 0.001). These effect sizes do not represent percentage improvements.

Studied regimen430 or 1,290 mg of product per day, equivalent to 300 or 900 mg of extract, respectively, taken in the morning as three capsules in total, including any placebo capsulescognitaven capsules containing green oat extract and excipients
Duration and population29 days, with tests on day 29 before the morning dose and 2 and 4 hours afterwardHealthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis

Comparator: Identical-looking maltodextrin capsules

Remembering a sequence of blocks: cognitaven2/4 LowRead moreCollapse
Confidence
2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company.

Improvement on a test of spatial working memory.

Study findings. On day 29, participants performed better on the Corsi block-sequence memory task. Averaged across the three measurements that day, the standardized difference versus placebo was d = 0.64 at 430 mg (p = 0.017) and d = 0.61 at 1,290 mg (p = 0.020).

Studied regimen430 or 1,290 mg of product per day, equivalent to 300 or 900 mg of extract, respectively, taken in the morning as three capsules in total, including any placebo capsulescognitaven capsules containing green oat extract and excipients
Duration and population29 days, with tests on day 29 before the morning dose and 2 and 4 hours afterwardHealthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis

Comparator: Identical-looking maltodextrin capsules

Other attention tasks: cognitaven2/4 LowRead moreCollapse
Confidence
2/4 LowThe final groups included 33 people on placebo, 33 on 430 mg, 32 on 860 mg, and 28 on 1,290 mg. The researchers assessed many tasks and time points. The result applies to this specific extract and the laboratory tasks used. It does not imply a corresponding change in memory or attention in everyday life. The manufacturer, Anklam Extrakt, funded the study. Two authors worked for the company.

No consistent improvement was detected on other tasks.

Study findings. The other tasks showed no consistent benefit over placebo. At 860 mg, accuracy on one attention test (RVIP) was lower 4 hours after the dose on day 29, with d = 0.62 (p < 0.001). No similar decline was seen on the other tests.

Studied regimen430, 860, or 1,290 mg of product per day, equivalent to 300, 600, or 900 mg of extract, taken in the morning as three capsules in total, including any placebo capsulescognitaven capsules containing green oat extract and excipients
Duration and population29 days, with tests on day 29 before the morning dose and 2 and 4 hours afterwardHealthy adults aged 35–65, with 132 assigned to four groups and 126 included in the day 29 analysis

Comparator: Identical-looking maltodextrin capsules

Attention with long-term Neuravena use2/4 LowRead moreCollapse
Confidence
2/4 LowIn this small crossover trial, 37 people completed both periods. The article did not describe a separate washout period between them. Testing for a sustained effect took place at least 18 hours after the last dose. The study did not assess effects in the first few hours after dosing. Participants had normal memory and attention at baseline. The authors accounted for multiple comparisons when evaluating many tests. Frutarom funded the study and supplied the capsules.

Long-term use did not improve the attention measures studied.

Study findings. No benefit was detected on tests of attention and concentration. On the primary color-naming test, the mean number of uncorrected errors was 2.2 with the extract and 2.1 with placebo (p = 0.72). The overall attention score also did not differ (p = 1.00).

Studied regimen1,500 mg of extract per day, taken as five capsules containing 300 mg of extract eachNeuravena EFLA955 green oat extract capsules
Duration and population12 weeks each of extract and placebo, for a total of 24 weeks. Testing took place at least 18 hours after the last dose.42 healthy people over 60 started the trial, and 37 completed both periods. The mean age was 67 years.

Comparator: Placebo capsules containing microcrystalline cellulose, lactose, and colorants

Safety and limitations

If you are allergic to oats, avoid oat foods and supplements. If you have celiac disease, choose oats labeled gluten-free because ordinary oat flakes may be contaminated with wheat, rye, or barley. Even pure oats cause symptoms in a small proportion of people with celiac disease because of the protein avenin. Discuss an appropriate amount with your doctor or dietitian. In the CP105F tablet trial, gastrointestinal adverse events were recorded in 23.4%, 34.8%, and 66.7% of participants taking 1.5, 3, and 6 g of beta-glucan per day, respectively, and in 36.9% of participants taking placebo. These figures apply to this specific product over 12 weeks. Because of insufficient data, EMA does not recommend using green oat herb preparations during pregnancy or breastfeeding or in children under 12. These restrictions apply to oat herb preparations. Oats eaten as ordinary food are outside their scope. Oat herb preparations may impair your ability to drive or operate machinery safely. If you experience this effect, avoid these activities. If you have celiac disease, also check the ingredients of the extract. Liquid preparations may contain alcohol.

Eating, Diet, & Nutrition for Celiac Disease - NIDDK ↗ · Coeliac disease - Treatment ↗ · Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗ · Community herbal monograph on Avena sativa L., herba (EMEA/HMPC/202966/2007) ↗

Interactions

WithEffectActionSource
Taking medicines with oat herb preparationsThe EMA monograph on oat herb lists no reported drug interactions.Check the instructions for the specific preparation to see whether it can be taken with your medicines.Community herbal monograph on Avena sativa L., herba (EMEA/HMPC/202966/2007) ↗

Food sources

The table lists oat foods and their calorie content. USDA SR28 does not list beta-glucan amounts for these entries, so the table does not rank foods by beta-glucan content. Total fiber cannot be used in place of beta-glucan. Serving sizes were chosen to make comparison easier. Porridge is weighed after cooking, while oat grain, rolled oats, and oat bran are weighed dry.

Food composition

FoodGroupAmountServingCaloriesSources
Oat grainDryOat foods—The USDA entry does not list the amount of beta-glucan.40 g · 156 kcal389 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗
Rolled oatsDry, unenrichedOat foods—The USDA entry does not list the amount of beta-glucan.40 g · 152 kcal379 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗
Oat branDryOat foods—The USDA entry does not list the amount of beta-glucan.20 g · 49 kcal246 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗
Oat bran porridgeCookedOat foods—The USDA entry does not list the amount of beta-glucan.150 g · 60 kcal40 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗
Oat bran breadPrepared breadOat foods—The USDA entry does not list the amount of beta-glucan.30 g · 71 kcal236 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗
Oat bran muffinBakedOat foods—The USDA entry does not list the amount of beta-glucan.50 g · 135 kcal270 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗

USDA National Nutrient Database for Standard Reference, Release 28 (SR28): ASCII data and documentation ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗LDL (“bad”) cholesterol: oat productsAdults with high cholesterol, with 12 trials and 13 dose comparisons for LDLOat milk, oat grain and porridge, rolled oats, bread, cookies, bars, soup, and beta-glucan concentrate. 1.5–6 g of oat beta-glucan per day for 3–8 weeks. Comparator: Products without added oat beta-glucan, such as bread, cornflakes, rice, a dairy product, or dextroseLDL was 0.27 mmol/L lower on average than in the control group (95% confidence interval for the reduction, 0.20–0.35 mmol/L).
Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial ↗LDL (“bad”) cholesterol: beta-glucan tablets263 adults with LDL above 3.37 mmol/L, including people who were taking statins and people who were notCP105F oat beta-glucan tablets containing 0.5 g of beta-glucan each. 1.5, 3, or 6 g of beta-glucan per day, taken as 1, 2, or 4 tablets three times a day for 12 weeks. Comparator: Placebo tabletsLDL did not decrease compared with placebo. Changes at 1.5, 3, and 6 g per day were +0.08, +0.11, and −0.04 mmol/L, respectively, compared with −0.10 mmol/L with placebo. The corresponding p-values were 0.23, 0.18, and 0.72.